Quinn N - Search Results

1

Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.

Stocchi F, Ruggieri S, Carta A, Ryatt J, Quinn N, Jenner P, Marsden CD, Agnoli A. Stocchi F, et al. Among authors: quinn n. Mov Disord. 1992;7(3):249-56. doi: 10.1002/mds.870070311. Mov Disord. 1992. PMID: 1620143 Clinical Trial.

2

Young onset Parkinson's disease.

Quinn N, Critchley P, Marsden CD. Quinn N, et al. Mov Disord. 1987;2(2):73-91. doi: 10.1002/mds.870020201. Mov Disord. 1987. PMID: 3504266

3

Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.

Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Schrag A, et al. Among authors: quinn n. Mov Disord. 1998 Nov;13(6):885-94. doi: 10.1002/mds.870130605. Mov Disord. 1998. PMID: 9827611

4

The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease.

Steiger MJ, Stocchi F, Bramante L, Ruggieri S, Quinn NP. Steiger MJ, et al. Among authors: quinn np. Clin Neuropharmacol. 1992 Dec;15(6):501-4. doi: 10.1097/00002826-199212000-00007. Clin Neuropharmacol. 1992. PMID: 1477849

5

The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.

Steiger MJ, Stocchi F, Carta A, Ruggieri S, Agnoli A, Quinn NP, Marsden CD. Steiger MJ, et al. Among authors: quinn np. Clin Neuropharmacol. 1991 Jun;14(3):241-4. doi: 10.1097/00002826-199106000-00007. Clin Neuropharmacol. 1991. PMID: 2070364

6

Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease.

Temlett JA, Quinn NP, Jenner PG, Marsden CD, Pourcher E, Bonnet AM, Agid Y, Markstein R, Lataste X. Temlett JA, et al. Among authors: quinn np. Mov Disord. 1989;4(3):261-5. doi: 10.1002/mds.870040307. Mov Disord. 1989. PMID: 2571082

7

The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results.

Coleman RJ, Lange KW, Quinn NP, Loper AE, Bondi JV, Hichens M, Stahl SM, Marsden CD. Coleman RJ, et al. Among authors: quinn np. Mov Disord. 1989;4(2):129-38. doi: 10.1002/mds.870040204. Mov Disord. 1989. PMID: 2733705 Free article.

8

Menstrual-related fluctuations in Parkinson's disease.

Quinn NP, Marsden CD. Quinn NP, et al. Mov Disord. 1986;1(1):85-7. doi: 10.1002/mds.870010112. Mov Disord. 1986. PMID: 3504235

9

Comparison between a fast and a slow release preparation of levodopa and a combination of the two: a clinical and pharmacokinetic study.

Stocchi F, Quinn NP, Barbato L, Patsalos PN, O'Connel MT, Ruggieri S, Marsden CD. Stocchi F, et al. Among authors: quinn np. Clin Neuropharmacol. 1994 Feb;17(1):38-44. doi: 10.1097/00002826-199402000-00004. Clin Neuropharmacol. 1994. PMID: 8149358 Clinical Trial.

10

Unilateral abolition of extrapyramidal rigidity after ipsilateral cerebellar infarction.

Rivest J, Quinn N, Gibbs J, Marsden CD. Rivest J, et al. Among authors: quinn n. Mov Disord. 1990;5(4):328-30. doi: 10.1002/mds.870050414. Mov Disord. 1990. PMID: 2259357 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

713 results

Search Page

Filters